Published - August 31th, 2023 @ 11:30 AM (GMT+2)
‍

J&J's Stock Performance

‍

Johnson & Johnson's (NYSE:JNJ) current stock price is $163.10, with a market cap of $394.26 billion. Over the past month, the stock has declined by 2.64%, but it has seen a modest increase of 1.09% since last year. Year-to-date, the stock is down by 8.47%, with an average trading volume of 32.84 million shares.
‍

Bank of America Securities recently reiterated a 'Hold' rating on J&J with a price target of $180. This comes amidst a backdrop of varying opinions from other financial institutions, including a 'Hold' from J.P. Morgan and a 'Buy' from Cantor Fitzgerald.

‍

‍

Earnings Growth Forecast - Impact of Kenvue Spinoff
‍

J&J has released its first earnings forecast as a standalone pharmaceutical and medical devices company, estimating a 12.5% increase in adjusted earnings per share for the year. The company expects earnings per share to be between $10 and $10.10.
‍

The spinoff of Kenvue has been one of the most significant shakeups in J&J's history. The company now maintains a 9.5% stake in Kenvue, which debuted on the New York Stock Exchange with a market capitalization of nearly $79 billion.

‍

Insider Activity
‍

Recent insider activity indicates a negative sentiment, with an increase in insiders selling their shares. Last month, Hait William, an insider at J&J, sold 14,698 shares for a total of $2,528,056.
‍

J&J's Future: Pharmaceutical and Medical Devices Focus
‍

Post-Kenvue, J&J is focusing more on its pharmaceutical and medical technology businesses. The company reported a quarterly revenue of $25.53 billion and a net profit of $5.14 billion for the quarter ending June 30.
‍

Conclusion
‍

Johnson & Johnson is at a pivotal moment, with its recent Kenvue spinoff and a focus on pharmaceuticals and medical devices. While the stock has seen some volatility, the company's double-digit earnings growth forecast offers a promising outlook.

Investors should keep an eye on insider activity and analyst ratings to make informed decisions.

‍

‍
The information on mexem.com is for general informational purposes only. It should not be regarded as investment advice. Investing in stocks involves risk. A stock's past performance is not a reliable indicator of its future performance. Always consult a financial advisor or trusted sources before making any investment decisions.
‍